Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 106 results.
User Information
Export Records
  1. 1.   Innate protection against intrarectal SIV acquisition by a live SHIV vaccine
  2. Sui, Yongjun; Meyer, Thomas J; Fennessey,Christine; Keele,Brandon; Dadkhah,Kimia; Ma, Chi; LaBranche, Celia C; Breed, Matthew W; Kramer,Josh; Li, Jianping; Howe, Savannah E; Ferrari, Guido; Williams, LaTonya D; Cam, Maggie; Kelly,Michael; Shen, Xiaoying; Tomaras, Georgia D; Montefiori, David; Greten, Tim F; Miller, Christopher J; Berzofsky, Jay A
  3. JCI Insight. 2024, May 21; 9(12):
  1. 2.   SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali
  2. Sylvain, Laverdure; Donatien, Kazadi; Kadidia, Kone; Viviane, Callier; Djeneba, Dabitao; Dehkontee, Dennis; Cherif, Haidara Mory; Sally, Hunsberger; Tshiani Mbaya,Olivier; Renee, Ridzon; Irini, Sereti; Katy, Shaw-Saliba
  3. International Journal of Infectious Diseases : IJID : official publication of the International Society for Infectious Diseases. 2024, Feb 26; 106985.
  1. 3.   Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers
  2. Bean, Rachel; Giurgea, Luca T; Han, Alison; Czajkowski, Lindsay; Cervantes-Medina, Adriana; Gouzoulis, Monica; Mateja,Allyson; Hunsberger, Sally; Reed, Susan; Athota, Rani; Baus, Holly Ann; Kash, John C; Park, Jaekeun; Taubenberger, Jeffery K; Memoli, Matthew J
  3. mBio. 2024, Jan 09; e0237223.
  1. 4.   Acute-phase innate immune responses in SIVmac239-infected Mamu-B*08+ Indian rhesus macaques may contribute to the establishment of elite control
  2. Rosen, Brandon C; Sawatzki, Kaitlin; Ricciardi, Michael J; Smith, Elise; Golez, Inah; Mauter, Jack T; Pedreño-López, Núria; Yrizarry-Medina, Aaron; Weisgrau, Kim L; Vosler, Logan J; Voigt, Thomas B; Louw, Johan J; Tisoncik-Go, Jennifer; Whitmore, Leanne S; Panayiotou, Christakis; Ghosh, Noor; Furlott, Jessica R; Parks, Christopher L; Desrosiers, Ronald C; Lifson,Jeffrey; Rakasz, Eva G; Watkins, David I; Gale, Michael
  3. Frontiers in Immunology. 2024 15: 1478063.
  1. 5.   Stereoselective Synthesis of Sialyl Lewisa Antigen and the Effective Anticancer Activity of Its Bacteriophage Qß Conjugate as an Anticancer Vaccine
  2. Rashidijahanabad, Zahra; Ramadan, Sherif; O'Brien, Nicholas; Nakisa, Athar; Lang, Shuyao; Crawford, Howard; Gildersleeve,Jeffrey; Huang, Xuefei
  3. Angewandte Chemie (International ed. in English). 2023, Oct 02; e202309744.
  1. 6.   Perspectives on Advancing Countermeasures for Filovirus Disease: Report from a Multi-Sector Meeting
  2. Sprecher, Armand; Cross, Robert; Marzi, Andrea; Martins, Karen A; Wolfe, Daniel; Montgomery, Joel M; Spiropoulou, Christina F; Cihlar, Tomas; Ahuka-Mundeke, Steve; Nyhuis, Tara; Teicher, Carrie; Crozier,Ian; Strong, Jim; Kobinger, Gary; Woolsey, Courtney; Geisbert, Thomas W; Feldmann, Heinz; Muyembe, Jean-Jacques
  3. The Journal of Infectious Diseases. 2023, Aug 19;
  1. 7.   The SeroNet Clinical and Translational Serology Task Force (CTTF) SARS-CoV-2 mucosal immunity methodological considerations and best practices workshop
  2. Hempel,Heidi; Mantis, Nicholas; Heaney, Christopher D; Pinto,Ligia
  3. Human Vaccines & Immunotherapeutics. 2023, Aug 01; 19(2): 2253598.
  1. 8.   SARS-CoV-2 IgG Spike antibody levels and avidity in natural infection or following vaccination with mRNA-1273 or BNT162b2 vaccines
  2. Hickey,Thomas; Kemp,Troy; Bullock,Jimmie; Bouk,Aaron; Metz,Jordan; Neish,Abigail; Cherry, James; Lowy, Douglas R; Pinto,Ligia
  3. Human Vaccines & Immunotherapeutics. 2023, Jun 01; 2215677.
  1. 9.   Vaccination Ameliorates Cellular Inflammatory Responses in SARS-CoV-2 Breakthrough Infections
  2. Huapaya, Julio A; Higgins, Jeanette; Kanth, Shreya; Demirkale, Cumhur; Gairhe, Salina; Aboye, Etsubdink A; Regenold, David; Sahagun, S J; Pastor, Gloria; Swaim, Doris; Dewar,Robin; Rehman,Tauseef; Highbarger,Helene; Lallemand,Perrine; Laverdure,Sylvain; Adelsberger, Joseph; Rupert,Adam; Li, Willy; Krack, Janell; Teferi, Gebeyehu; Kuruppu, Janaki; Strich, Jeffrey R; Davey, Richard; Childs, Richard; Chertow, Daniel; Kovacs, Joseph A; Barnett, Christopher; Torabi-Parizi, Parizad; Suffredini, Anthony F
  3. The Journal of Infectious Diseases. 2023, Feb 18;
  1. 10.   The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next Steps
  2. Crozier,Ian; Britson, Kyla A; Wolfe, Daniel N; Klena, John D; Hensley, Lisa E; Lee, John S; Wolfraim, Larry A; Taylor, Kimberly L; Higgs, Elizabeth S; Montgomery, Joel M; Martins, Karen A
  3. Vaccines. 2022, Jul 29; 10(8):
  1. 11.   Cytidine acetylation yields a hypoinflammatory synthetic messenger RNA
  2. Nance,Kellie; Thalalla Gamage,Supuni; Alam,Md Masud; Yang,Acong; Levy, Michaella J; Link,Courtney; Florens, Laurence; Washburn, Michael P; Gu,Shuo; Oppenheim,Joost; Meier,Jordan
  3. Cell Chemical Biology. 2022, Feb 17; 29(2): 312-320.e7.
  1. 12.   Recombinant Herpesvirus Vectors: Durable Immune Responses and Durable Protection against Simian Immunodeficiency Virus SIVmac239 Acquisition
  2. Castro, Isabelle M.; Ricciardi, Michael J.; Gonzalez-Nieto, Lucas; Rakasz, Eva G.; Lifson,Jeffrey; Desrosiers, Ronald C.; Watkins, David; Martins, Mauricio A.
  3. Journal of Virology . 2021, Jun 24; 95(14):
  1. 13.   Temporal Dominance of B.1.1.7 over B.1.354 SARS-CoV-2 Variant: A Hypothesis Based on Areas of Variant Co-Circulation
  2. Kostaki, Evangelia Georgia; Tseti, Ioulia; Tsiodras, Sotirios; Pavlakis,George; Sfikakis, Petros P.; Paraskevis, Dimitrios
  3. Life (Basel, Switzerland). 2021, May; 11(5):
  1. 14.   Design of Alphavirus Virus-Like Particles Presenting Circumsporozoite Junctional Epitopes That Elicit Protection against Malaria
  2. Francica, Joseph R.; Shi, Wei; Chuang, Gwo-Yu; Chen, Steven J.; Da Silva Pereira, Lais; Farney, S. Katie; Flynn, Barbara J.; Ou, Li; Stephens, Tyler; Tsybovsky,Yaroslav; Wang, Lawrence T.; Anderson, Alexander; Beck, Zoltan; Dillon, Marlon; Idris, Azza H.; Hurlburt, Nicholas; Liu, Tracy; Zhang, Baoshan; Alving, Carl R.; Matyas, Gary R.; Pancera, Marie; Mascola, John R.; Kwong, Peter D.; Seder, Robert A.
  3. Vaccines. 2021, Mar 18; 9(3):
  1. 15.   Induction of Cytokines by Nucleic Acid Nanoparticles (NANPs) Depends on the Type of Delivery Carrier
  2. Avila, Yelixza I.; Chandler, Morgan; Cedrone,Edward; Newton,Hannah; Richardson, Melina; Xu,Jie; Clogston,Jeffrey; Liptrott, Neill J.; Afonin, Kirill A.; Dobrovolskaia,Marina
  3. Molecules. 2021, Feb; 26(3):
  1. 16.   Networks of HIV-1 Envelope Glycans Maintain Antibody Epitopes in the Face of Glycan Additions and Deletions
  2. Seabright, Gemma E; Cottrell, Christopher A; van Gils, Marit J; D'addabbo, Alessio; Harvey, David J; Behrens, Anna-Janina; Allen, Joel D; Watanabe, Yasunori; Scaringi, Nicole; Polveroni, Thomas M; Maker, Allison; Vasiljevic, Snezana; De Val Alda,Natalia; Sanders, Rogier W; Ward, Andrew B; Crispin, Max
  3. Structure (London, England : 1993). 2020, AUG 4; 28(8): 897-+.
  1. 17.   Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection
  2. Gay, Cynthia L; Kuruc, Joann D; Falcinelli, Shane D; Warren, Joanna A; Reifeis, Sarah A; Kirchherr, Jennifer L; James, Katherine S; Dewey, Morgan G; Helms, Alyson; Allard, Brigitte; Stuelke, Erin; Gamble, Alicia; Plachco, Ana; Gorelick,Robert; Eron, Joseph J; Hudgens, Michael; Garrido, Carolina; Goonetilleke, Nilu; DeBenedette, Mark A; Tcherepanova, Irina Y; Nicolette, Charles A; Archin, Nancie M; Margolis, David M
  3. Scientific reports. 2020, Mar 20; 10(1): 5134.
  1. 18.   Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies
  2. Dobrovolskaia,Marina
  3. Molecules (Basel, Switzerland). 2019, Dec; 24(24):
  1. 19.   Anti-glycan IgM repertoires in newborn human cord blood
  2. Xia, Li; Gildersleeve,Jeffrey
  3. PloS one. 2019, JUL 31; 14(7): e0218575.
  1. 20.   A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide
  2. Trabbic,Kevin; Whalen, Kaitlyn; Abarca-Heideman, Karin; Xia, Li; Temme,Sebastian; Edmondson,Elijah; Gildersleeve,Jeffrey; Barchi,Joe
  3. Scientific reports. 2019, Apr 5; 9(1):
  1. 21.   The Frequency of Vaccine-Induced T-Cell Responses Does Not Predict the Rate of Acquisition after Repeated Intrarectal SIVmac239 Challenges in Mamu-B*08(+) Rhesus Macaques
  2. Martins, Mauricio A.; Gonzalez-Nieto, Lucas; Shin, Young C.; Domingues, Aline; Gutman, Martin J.; Maxwell, Helen S.; Magnani, Diogo M.; Ricciardi, Michael J.; Pedreno-Lopez, Nuria; Bailey, Varian K.; Altman, John D.; Parks, Christopher L.; Allison, David B.; Ejima, Keisuke; Rakasz, Eva G.; Capuano, Saverio; Desrosiers, Ronald C.; Lifson, Jeffrey; Watkins, David
  3. Journal of virology. 2019, Feb 19; 93
  1. 22.   Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages
  2. Corbett, Kizzmekia S; Moin, Syed M; Yassine, Hadi M; Cagigi, Alberto; Kanekiyo, Masaru; Boyoglu-Barnum, Seyhan; Myers, Sky I; Tsybovsky, Yaroslav; Wheatley, Adam K; Schramm, Chaim A; Gillespie, Rebecca A; Shi, Wei; Wang, Lingshu; Zhang, Yi; Andrews, Sarah F; Joyce, M Gordon; Crank, Michelle C; Douek, Daniel C; McDermott, Adrian B; Mascola, John R; Graham, Barney S; Boyington, Jeffrey C
  3. mBio. 2019, Jan-Feb; 10(1): pii: e02810-18.
  1. 23.   Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development
  2. Pinto, Ligia; Dillner, Joakim; Beddows, Simon; Unger, Elizabeth R
  3. Vaccine. 2018, Aug 06; 36(32 Pt. A): 4792-4799.
  1. 24.   Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during simian-human immunodeficiency virus infection
  2. Munson, Paul; Liu, Yi; Bratt, Debra; Fuller, James T; Hu, Xintao; Pavlakis, George; Felber, Barbara; Mullins, James I; Fuller, Deborah Heydenburg
  3. Human vaccines & immunotherapeutics. 2018, Apr 12; 14(7): 1820-1831.
  1. 25.   Addressing barriers to effective cancer immunotherapy with nanotechnology: Achievements, challenges, and roadmap to the next generation of nanoimmunotherapeutics
  2. Hong, Enping; Dobrovolskaia, Marina
  3. Advanced drug delivery reviews. 2018, Feb 15; 141: 3-22.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel